Viewing Study NCT05652192


Ignite Creation Date: 2025-12-24 @ 3:29 PM
Ignite Modification Date: 2025-12-26 @ 9:24 AM
Study NCT ID: NCT05652192
Status: RECRUITING
Last Update Posted: 2022-12-15
First Post: 2022-11-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: SBRT Combined With Chemotherapy and Tislelizumab in Metastatic NPC
Sponsor:
Organization: